Main Article Content
Introduction: Placenta percreta is an abnormality of placentation where it invades the serosa and can go beyond it. Complications include massive hemorrhage, bladder dysfunction, and severe infections during delivery. The aim of this study is to report a complex case of placenta percreta managed by interval hysterectomy.
Case presentation: Pre-operative: 34 years old patient with previous three cesarean sections was followed in antenatal clinic. She came with repeated bouts of vaginal bleeding at 30-31 weeks. At 32 weeks and 4 days classical cesarean section was done with placenta left in situ. Prophylactic bilateral internal iliac artery balloon was inserted. Post cesarean section, uterine artery embolization was performed. Post-operative: Clinical features of pulmonary embolism (PE) developed about 4 hours later. Post-Operative Day 13: Total abdominal hysterectomy was done. After few days of discharge, the patient presented to the emergency department with shortness of breath. She was consequently diagnosed with chronic pulmonary embolism and treated with warfarin.
Conclusion: This is a case of placenta percreta managed by interval hysterectomy. However, the most widely accepted method of management is cesarean hysterectomy. In this case, interval hysterectomy was done due to the possibility of bladder invasion by placenta, to decrease the amount of blood loss and to reduce the number of days stayed in hospital. Appropriate management for the patient must be personalized, whether it is by cesarean hysterectomy or interval hysterectomy, as each has risks and benefits.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site;
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Revised 7/16/2018. Revision Description: Removed outdated link.
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and Risk Factors for Placenta Accreta/Increta/Percreta in the UK: A National Case-Control Study. PLoS One. 2012;7(12):e52893.
Ibrahim MA, Liu A, Dalpiaz A, Schwamb R, Warren K, Khan SA. Urological Manifestations of Placenta Percreta. Curr Urol. 2015;8(2):57-65.
Hudon L, Belfort MA, Broome DR. Diagnosis and management of placenta percreta: a review. Obstet Gynecol Surv. 1998;53:509–517.
Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am. J. Obstet. Gynecol. 2005;192(5):1458–1461.
Price FV, Resnik E, Heller KA, Christopherson WA. Placenta previa percreta involving the urinary bladder: a report of two cases and review of the literature. Obstet Gynecol. 1991;78:508-511.
Placenta Accreta Spectrum. Obstetric Care Consensus. 2018;132(6):259-17. Available from: https://www.acog.org/-/media/Obstetric-Care-Consensus-Series/occ007.pdf?dmc=1&ts=20181129T1453250701. Accessed on January 28, 2019.
Farquhar CM, Li Z, Lensen S et al. Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand: a case–control study. BMJ Open. 2017;7(10):e017713.
Rajkumar B, Kumar N, Sowmya S. Placenta percreta in primigravida, an unsuspected situation. Int Jour of Reprod, Contracept, Obs & Gyn [Internet]. 2014;3(1). Available from: http://www.ijrcog.org/index.php/ijrcog/article/view/830. Accessed on January 28, 2019.
Wright JD, Pri-Paz S, Herzog TJ. Predictors of massive blood loss in women with placenta accreta. Am. J. Obstet. Gynecol. 2011;205(38):1-6.
Sentilhes. Maternal outcome after conservative treatment of placenta accreta. Obstet. Gynecol. 2010;115(3):526–534.
Konijeti R, Rajfer J, Askari A. Placenta Percreta and the Urologist. Rev Urol. 2009;11(3):173–176.
Fay EE, Norquist B, Jolley J, Hardesty M. Conservative Management of Invasive Placentation: Two Cases with Different Surgical Approaches. AJP Rep. 2016;6(2):212–215.
Wong VV1, Burke G. Planned conservative management of placenta percreta. J Obstet Gynaecol. 2012;32(5):447-52.
Emily W, Stephanie C, Noelle B, Yongmei H, William B, Annette P. Surgical Management of Placenta Percreta: Outcomes of Immediate Versus Interval Hysterectomy. Obstetrics & Gynecology. 2018;131(117S). Available from: https://journals.lww.com/greenjournal/Abstract/2018/05001/Surgical_Management_of_Placenta_Percreta__.406.aspx. Accessed on January 28, 2019.